Articles On Zelda Therapeutics (ASX:ZLD)

Do you know that market enthusiasts believe that legalising cannabis would generate approximately $8.5 billion in the country’s federal and state tax? Ponder over the massive revenue that this sector would add to the necessities related to...

Zelda Therapeutics (ASX:ZLD) is no stranger to testing for positive health effects derived from medicinal cannabis products. In its latest step, the company has obtained approval to test for the viability of medical marijuana in the treatme...

The phase I trial will begin immediately with preliminary results expected later this quarter and full results in quarter four of 2019.

Bio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has taken a decisive step towards mitigating the effects of the growing opioid epidemic that is gripping several Western countries including Australia and the US. Earlier today, Zelda...

Zelda Therapeutics (ASX:ZLD) has announced that its phase 1 Opioid Reduction Trial has been formally approved by the St Vincent’s Hospital Ethics and Governance Committees.

One of Australia's leading cannabis companies Zelda Therapeutics (ASX: ZLD) has been given the greenlight to commence an opioid reduction trial. The trial at St Vincent's Hospital in Melbourne will see Zelda assess the effectiveness of me...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

The company’s medicinal cannabis products are aimed at treating pain, anxiety, sleep apnea and cancer.